Equity in Focus : Investigating Gender Disparities in Glioblastoma via Propensity Score Matching

TL;DR

This study uses propensity score matching on TCGA data to investigate gender disparities in glioblastoma outcomes, revealing higher incidence in males after controlling for confounders, and highlights the need for gender-specific treatment strategies.

Contribution

It applies propensity score matching to molecular and demographic data to rigorously analyze gender differences in GBM outcomes, addressing confounding biases in observational studies.

Findings

Higher GBM incidence in males after adjustment

Balanced male-female groups with similar baseline characteristics

Results suggest gender-specific differences in GBM outcomes

Abstract

Gender disparities in health outcomes have garnered significant attention, prompting investigations into their underlying causes. Glioblastoma (GBM), a devastating and highly aggressive form of brain tumor, serves as a case for such inquiries. Despite the mounting evidence on gender disparities in GBM outcomes, investigations specific at the molecular level remain scarce and often limited by confounding biases in observational studies. In this study, I aimed to investigate the gender-related differences in GBM outcomes using propensity score matching (PSM) to control for potential confounding variables. The data used was accessed from the Cancer Genome Atlas (TCGA), encompassing factors such as gender, age, molecular characteristics and different glioma grades. Propensity scores were calculated for each patient using logistic regression, representing the likelihood of being male based on the baseline characteristics. Subsequently, patients were matched using the nearest-neighbor (with a restricted caliper) matching to create a balanced male-female group. After PSM, 303 male-female pairs were identified, with similar baseline characteristics in terms of age and molecular features. The analysis revealed a higher incidence of GBM in males compared to females, after adjusting for potential confounding factors. This study contributes to the discourse on gender equity in health, paving the way for targeted interventions and improved outcomes, and may guide efforts to improve gender-specific treatment strategies for GBM patients. However, further investigations and prospective studies are warranted to validate these findings and explore additional factors that might contribute to the observed gender-based differences in GBM outcomes aside from the molecular characteristics.